ESC 365 - Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

ESC Premium Access

Thromboembolism and bleeding in adults with congenital heart disease using non-vitamin K antagonist oral anticoagulants for thromboembolic prevention: a prospective worldwide observational study

Session: Drug therapy in congenital heart disease - What are the options and the needs?

Topic: Pharmacotherapy

Speaker: Miss H. Yang (Singapore, SG)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Miss Hayang Yang

National University of Singapore, Singapore (Singapore)

0 follower

4 more presentations in this session

Thromboembolic prevention in adolescents and adults with Fontan circulation: Is ASS a therapeutical option in long-standing Fontan circulation?

Speaker: Assistant Professor M. Westhoff-Bleck (Hannover, DE)

Combination of fenestrated atrial septal occluder with targeted medical therapy in patients with secundum atrial septal defect and severe pulmonary arterial hypertension

Speaker: Doctor C. Yan (Beijing, CN)

Drug therapy in adult congenital heart disease: the burden of polypharmacy

Speaker: Ms O. Woudstra (Amsterdam, NL)

Selective Heart Rate inhibition improves inadequate exercise response in Fontan Circulation

Speaker: Mr B. Ruijsink (London, GB)

Access the full session

Drug therapy in congenital heart disease - What are the options and the needs?

Speakers: Miss H. Yang, Assistant Professor M. Westhoff-Bleck, Doctor C. Yan, Ms O. Woudstra, Mr B. Ruijsink

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources